108128-12-7 Usage
Uses
Used in Pharmaceutical Industry:
Methyl 6-azaindole-3-carboxylate is used as a building block in the synthesis of various pharmaceuticals for its unique structural and chemical properties, contributing to the development of new drugs.
Used in Agrochemical Industry:
Methyl 6-azaindole-3-carboxylate is employed in the preparation of agrochemicals, leveraging its versatile reactivity and applications in chemical transformations to develop effective agricultural products.
Used in Materials Science:
Methyl 6-azaindole-3-carboxylate is utilized in the creation of new materials, taking advantage of its structural properties to enhance material performance in various applications.
Used in Organic Chemistry Research:
Methyl 6-azaindole-3-carboxylate serves as a valuable tool for researchers in organic chemistry, facilitating various chemical transformations and contributing to the advancement of the field.
Check Digit Verification of cas no
The CAS Registry Mumber 108128-12-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,8,1,2 and 8 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 108128-12:
(8*1)+(7*0)+(6*8)+(5*1)+(4*2)+(3*8)+(2*1)+(1*2)=97
97 % 10 = 7
So 108128-12-7 is a valid CAS Registry Number.
108128-12-7Relevant articles and documents
[4[4-(5-AMINOMETHYL-2-FLUORO-PHENYL)-PIPERIDIN-1-YL]-(1H-PYRROLO-PYRIDIN-YL)-METHANONES AND SYNTHESIS THEREOF
-
Page/Page column 40; 41, (2011/07/09)
The present invention relates herein to compounds and compositions for the treatment and amelioration of inflammatory disease. Specifically the present invention relates to compounds that having a tryptase inhibition activity and the intermediates thereof, pharmaceutical compositions comprising such compounds, and a method of treating subjects suffering from a condition disease or disorder that can be ameliorated by the administration of an inhibitor of tryptase including but not limited to for example asthma and other inflammatory diseases including age-related macular degeneration.